Heron Therapeutics (HRTX) 10-Q2011 Q1 Quarterly report

Filed: 16 May 11, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigious
Readability	H.S. freshman Good

New words: accredited, anniversary, annum, assessment, bear, bridge, chemotherapy, Concurrent, conversion, emetogenic, extended, Factor, half, lease, loan, moderately, occur, OTC, OTCQB, ownership, payable, penny, Pink, principal, pro, projected, promptly, property, rata, secured, senior, statement, suitability, undergoing

Removed: accept, accomplished, acquiring, Additionally, addressed, adequately, adverse, adversely, agency, agreeing, announced, announcement, applicable, appointed, approach, approve, approving, arise, attain, attainment, beginning, bioavailability, biological, borrowing, cancelled, cap, capable, capacity, cease, civil, clarification, combination, commitment, comparable, competitive, compliance, comply, concept, confirmatory, connection, conserve, consistently, consolidate, consuming, continuing, corrective, costly, create, criminal, criteria, deducting, degree, delay, demonstrate, demonstrated, design, designate, designated, designee, determine, determined, dilution, diminish, disclosed, discovery, discretion, dosing, duration, earning, efficacy, eliminate, enable, enhance, entail, enter, entitle, entity, event, exchanged, exercisability, exercise, exercised, existing, expenditure, expire, expired, expressed, face, facility, Failure, feasible, fiscal, foreign, gain, gamma, generate, good, granted, harm, human, iii, implement, important, impose, imposition, improper, increased, incur, inspection, inspectional, interpretation, interruption, irradiation, issuance, manner, manufacture, manufacturer, marketable, marketed, maximum, meeting, merge, metabolism, monetary, November, observed, obtained, offering, offset, partially, Participating, patient, permissible, permit, pledge, power, preclude, present, presently, prevent, previously, producing, proposed, prosecution, purpose, QT, reach, recall, redeem, redeemable, redeemed, refusal, registering, relating, relevant, relied, relinquish, representative, request, requesting, requiring, reserved, resolution, resource, restrict, restrictive, resubmitted, revision, satisfactory, satisfied, satisfy, seizure, select, similar, Similarly, specific, stability, Stephen, sterility, sterilization, stringent, study, submit, submitted, subsequently, successive, suffer, support, supporting, susceptible, suspension, syringe, technical, terminal, transfer, unanticipated, uncertain, underlying, unexercised, unfavorable, United, unknown, validation, varying, waive, warning, withdrawal

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

HRTX similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of A.P. Pharma, Inc. (the “Company”) on Form 10-Q for the period ending March 31, 2011 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, John B. Whelan, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1)

the Report fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934, as amended; and

(2)

the information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

May 16, 2011

/s/ John B. Whelan

John B. Whelan

Chief Executive Officer